Claims for Patent: 10,106,591

Summary for Patent: 10,106,591

Title:	BMP peptides and methods of use
Abstract:	The invention relates to truncated growth factors and variants thereof. The invention also relates to methods of making and using the truncated growth factors. The invention further relates to compositions including a protease and a growth factor comprising a bone morphogenic protein (BMP) or a variant thereof. The invention also relates to methods of using the composition.
Inventor(s):	Qin; Xiaofei (Virginia Beach, VA), Chen; Silvia (Virginia Beach, VA), Chen; Jingsong (Virginia Beach, VA), Clagett; James (Virginia Beach, VA)
Assignee:	LifeNet Health (Virginia Beach, VA)
Application Number:	15/690,418
Patent Claims:	1. A peptide consisting of an amino acid sequence selected from SEQ ID NOs: 20, 21, 22, 24, 25, 26, 27 and 28. 2. A pharmaceutical composition comprising the peptide of claim 1 and a pharmaceutically acceptable carrier. 3. A method of increasing a biological activity of a cell, comprising treating the cell with an effective amount of the composition of claim 2, wherein the biological activity is selected from the group consisting of osteoinductive activity, chondroinductive activity, ligament/tendon differentiating activity, osteogenic activity and growth factor activity. 4. The method of claim 3, wherein the cell is derived from placenta, bone marrow, adipose tissue, blood vessel, amniotic fluid, synovial fluid, synovial membrane, pericardium, periosteum, dura, peripheral blood, umbilical blood, menstrual blood, teeth, nucleus pulposus, brain, skin, hair follicle, intestinal crypt, neural tissue, or muscle. 5. The method of claim 3, wherein the cell is a progenitor cell or adult stern cell. 6. The method of claim 3, wherein the cell is a pluripotent stem cell. 7. The method of claim 3, wherein the cell is selected from the group consisting of mesenchymal stem cells, adipose-derived stem cells, embryonic stem cells, progenitor cells, differentiated cells, undifferentiated cells, and induced pluripotent stem cells. 8. The method of claim 3, wherein the biological activity is an osteoinductive activity. 9. The method of claim 3, wherein the biological activity is a chondroinductive activity. 10. The method of claim 3, wherein the biological activity is a ligament/tendon differentiating activity. 11. The method of claim 3, wherein the biological activity is an osteogenic activity. 12. The method of claim 3, wherein the biological activity is a growth factor activity. 13. The method of claim 3, wherein the cell is in a tissue. 14. The method of claim 13, wherein the tissue is a bone, cartilage, or connective tissue. 15. The method of claim 3, wherein the composition further comprises a protease that is not bone morphogenetic protein-1 (BMP-1). 16. The method of claim 15, wherein the protease is selected from the group consisting of dispase, collagenase and a mixture thereof. 17. The method of claim 15, wherein the protease is collagenase. 18. The method of claim 15, wherein the protease is dispase. 19. A method of increasing a biological activity of a cell, comprising treating the cell with an effective amount of a peptide consisting of an amino acid sequence selected from SEQ ID NOs: 20-28, wherein the biological activity is selected from the group consisting of osteoinductive activity, chondroinductive activity, ligament/tendon differentiating activity, osteogenic activity and growth factor activity.

Details for Patent 10,106,591

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2031-09-02